Abstraction Health

Quercetin — Research Evidence

Source: PubMed / NCBI · human studies preferred · ranked by evidence qualityLast analyzed: May 24, 2026
🟡Moderate Evidence
21 studies·1 RCTs·17 reviews

The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.

Quercetin is a naturally occurring flavonoid polyphenol found in common foods such as onions, capers, apples, and kale, and has been the subject of scientific investigation for several decades. The available literature — consisting primarily of reviews and systematic reviews, with a small number of meta-analyses — suggests quercetin has broad biological activity, including antioxidant, anti-inflammatory, anti-allergic, and potentially cardioprotective properties. However, the majority of expert claims about quercetin's specific health benefits were rated as having insufficient evidence, meaning the research base, while active, has not yet produced consistent, high-quality human trial data to firmly support many of the therapeutic applications being discussed. Across the 15 available publications, the strongest evidence comes from meta-analyses examining quercetin's effects on blood pressure and its bioavailability in humans, as well as systematic reviews on bone metabolism and cardiovascular risk reduction. These higher-quality studies suggest quercetin supplementation may modestly influence blood pressure and that its bioavailability varies considerably depending on the delivery format. Systematic reviews also touch on quercetin's potential roles in rheumatoid arthritis disease activity and bone health, though findings across these areas are not consistently robust. Reviews covering inflammation, allergy, exercise-induced muscle damage, Alzheimer's prevention, diabetes management, and anti-aging applications exist but are largely narrative in nature and do not provide the same level of evidential weight. A major limitation across this evidence base is that the majority of publications are reviews rather than original clinical trials — and even the systematic reviews frequently draw on studies with small sample sizes, heterogeneous populations, and variable dosing protocols. Crucially, none of the listed studies report specific participant populations or sample sizes, which makes it difficult to assess how broadly any findings apply. More than 70% of the expert claims analyzed were classified as having insufficient evidence, underscoring that quercetin remains a supplement with considerable theoretical and preclinical support but limited definitive human trial data. Key unknowns include optimal dosing, long-term safety at supplemental doses, and whether benefits observed in controlled settings translate to real-world outcomes.

Key findings

  • Quercetin is a well-characterized flavonoid polyphenol found in many common plant-based foods and has been studied for decades for its antioxidant and anti-inflammatory properties.
  • A meta-analysis suggests quercetin supplementation may have a modest effect on reducing blood pressure, though the magnitude and clinical significance remain unclear.
  • Bioavailability of quercetin varies substantially depending on the supplement form used, as highlighted by a systematic review and meta-analysis on human intervention studies.
  • Systematic reviews indicate potential but inconsistent benefits for bone metabolism, cardiovascular risk reduction, and rheumatoid arthritis disease activity.
  • Anti-allergic and immune-modulating effects of quercetin are supported by mechanistic reviews, but direct human clinical evidence remains limited.

Evidence gaps

  • ?The vast majority of claims about quercetin's therapeutic benefits lack sufficient human clinical trial evidence — most support comes from in vitro, animal, or low-quality human studies.
  • ?Optimal supplemental dosing, timing, and formulation for specific health outcomes have not been established in well-designed, large-scale human trials.
  • ?Long-term effects and safety of quercetin supplementation at doses commonly used in supplements have not been thoroughly evaluated in human populations.

Safety summary

A dedicated review on the safety of quercetin as a dietary supplement suggests it is generally well-tolerated at typical supplemental doses, with no major adverse effects reported in short-term use. However, long-term safety data in humans remains limited, and caution is warranted at high doses or when combined with certain medications.

Studies (21)

The Effects of Quercetin Supplementation on Blood Pressure - Meta-Analysis.

Current problems in cardiology · 2022 · Popiolek-Kalisz J et al.
Meta-Analysis🟢
Key finding

The Effects of Quercetin Supplementation on Blood Pressure - Meta-Analysis.

PMID: 35948195DOI: 10.1016/j.cpcardiol.2022.101350
View on PubMed

Improving quercetin bioavailability: A systematic review and meta-analysis of human intervention studies.

Food chemistry · 2025 · Liu L et al.
Meta-Analysis🟢
Key finding

Improving quercetin bioavailability: A systematic review and meta-analysis of human intervention studies.

COI: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Gary Williamson reports a relationship with Access Business Group LLC West Coast Office that includes: consulting or advisory and funding grants. Gary Williamson reports a relationship with The Product Makers, Australia that includes: funding grants. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PMID: 40037045DOI: 10.1016/j.foodchem.2025.143630
View on PubMed

Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials.

Critical reviews in food science and nutrition · 2017 · Sahebkar A
Meta-Analysis🟢
Key finding

Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials.

Funded by: Industry (inferred from affiliations)
PMID: 25897620DOI: 10.1080/10408398.2014.948609
View on PubMed

Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.

Nutrients · 2022 · Inchingolo AD et al.
Systematic Review🟢
Key finding

Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.

Funded by: European Social Found, Human Capital Operational Programme 2014-2020
COI: The authors declare no conflict of interest.
PMID: 36079777DOI: 10.3390/nu14173519
View on PubMed

Micronutrient Supplementation to Reduce Cardiovascular Risk.

Journal of the American College of Cardiology · 2022 · An P et al.
Systematic Review🟢
Key finding

Micronutrient Supplementation to Reduce Cardiovascular Risk.

Funded by: NIEHS NIH HHS
COI: Funding Support and Author Disclosures This work was partly supported by the United States’ Fulbright Program where S.L. was a Fulbright Distinguished Chair in Global Health 2019-2020, and this work was supported by the Beijing Advanced Innovation Center for Food Nutrition and Human Health, the National Natural Science Foundation of China (31970717, 82170429), the Chinese Universities Scientific Fund (2020TC015), and the Beijing Municipal Natural Science Foundation (7222111). Dr Liu has received consulting payments and honoraria or promises of the same for scientific presentations or reviews at numerous venues, including but not limited to Johns Hopkins University, Fred Hutchinson Cancer Center, Harvard University, University of Buffalo, Guangdong General Hospital, Fuwai Hospital, Chinese Academy of Medical Sciences, and the National Institutes of Health; is a member of the Data Safety and Monitoring Board for several trials, including the SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) trial sponsored by Novo Nordisk and a trial of pulmonary hypertension in diabetes patients sponsored by Massachusetts General Hospital; and has received royalties from UpToDate; and has received an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr Mechanick has received honoraria from Abbott Nutrition for lectures; and serves on the advisory boards of Aveta.Life, L-Nutra, and Twin Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PMID: 36480969DOI: 10.1016/j.jacc.2022.09.048
View on PubMed

Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials.

Nutrients · 2020 · Nelson J et al.
Systematic Review🟢
Key finding

Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials.

COI: The authors declare no conflict of interest.
PMID: 33003645DOI: 10.3390/nu12102991
View on PubMed

Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction: a randomized, placebo-controlled, double-blind parallel-group study.

European review for medical and pharmacological sciences · 2022 · Yamada S et al.
RCT🟡
Key finding

Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction: a randomized, placebo-controlled, double-blind parallel-group study.

Funded by: Industry (inferred from affiliations)
PMID: 35776034DOI: 10.26355/eurrev_202206_29072
View on PubMed

Quercetin, Inflammation and Immunity.

Nutrients · 2016 · Li Y et al.
Review🟡
Key finding

Quercetin, Inflammation and Immunity.

PMID: 26999194DOI: 10.3390/nu8030167
View on PubMed

Dietary Supplementation for Attenuating Exercise-Induced Muscle Damage and Delayed-Onset Muscle Soreness in Humans.

Nutrients · 2021 · Tanabe Y et al.
Review🟡
Key finding

Dietary Supplementation for Attenuating Exercise-Induced Muscle Damage and Delayed-Onset Muscle Soreness in Humans.

COI: The author declares no conflict of interest.
PMID: 35010943DOI: 10.3390/nu14010070
View on PubMed

Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.

British journal of pharmacology · 2017 · Shen CY et al.
Review🟡
Key finding

Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.

PMID: 27659301DOI: 10.1111/bph.13631
View on PubMed

Novel Nutraceutical Compounds in Alzheimer Prevention.

Biomolecules · 2022 · Maccioni RB et al.
Review🟡
Key finding

Novel Nutraceutical Compounds in Alzheimer Prevention.

COI: The authors declare no conflict of interest.
PMID: 35204750DOI: 10.3390/biom12020249
View on PubMed

Safety Aspects of the Use of Quercetin as a Dietary Supplement.

Molecular nutrition & food research · 2018 · Andres S et al.
Review🟡
Key finding

Safety Aspects of the Use of Quercetin as a Dietary Supplement.

PMID: 29127724DOI: 10.1002/mnfr.201700447
View on PubMed

Therapeutic Potential and Clinical Effectiveness of Quercetin: A Dietary Supplement.

Recent advances in food, nutrition & agriculture · 2024 · Devi V et al.
Review🟡
Key finding

Therapeutic Potential and Clinical Effectiveness of Quercetin: A Dietary Supplement.

Funded by: Industry (inferred from affiliations)
PMID: 38258783DOI: 10.2174/012772574X269376231107095831
View on PubMed

Quercetin and Its Anti-Allergic Immune Response.

Molecules (Basel, Switzerland) · 2016 · Mlcek J et al.
Review🟡
Key finding

Quercetin and Its Anti-Allergic Immune Response.

COI: The authors declare no conflict of interest.
PMID: 27187333DOI: 10.3390/molecules21050623
View on PubMed

The Role of Macronutrients, Micronutrients and Flavonoid Polyphenols in the Prevention and Treatment of Osteoporosis.

Nutrients · 2022 · Martiniakova M et al.
Review🟡
Key finding

The Role of Macronutrients, Micronutrients and Flavonoid Polyphenols in the Prevention and Treatment of Osteoporosis.

Funded by: Ministry of Education, Science, Research and Sport of the Slovak Republic
COI: The authors declare no conflict of interest.
PMID: 35276879DOI: 10.3390/nu14030523
View on PubMed

Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022 · Dhanya R
Review🟡
Key finding

Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy.

Funded by: Industry (inferred from affiliations)
PMID: 34953390DOI: 10.1016/j.biopha.2021.112560
View on PubMed

Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies?

Cells · 2023 · Kaag S et al.
Review🟡
Key finding

Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies?

COI: The authors declare no conflict of interest.
PMID: 37998337DOI: 10.3390/cells12222602
View on PubMed

Dietary supplements for treatment of endometriosis: A review.

Acta bio-medica : Atenei Parmensis · 2022 · Yalçın Bahat P et al.
Review🟡
Key finding

Dietary supplements for treatment of endometriosis: A review.

COI: Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.
PMID: 35315418DOI: 10.23750/abm.v93i1.11237
View on PubMed

Health-promoting components of fruits and vegetables in the diet.

Advances in nutrition (Bethesda, Md.) · 2013 · Liu RH
Review🟡
Key finding

Health-promoting components of fruits and vegetables in the diet.

COI: Author disclosure: R. H. Liu, no conflicts of interest.
PMID: 23674808DOI: 10.3945/an.112.003517
View on PubMed

Advances and Perspectives on the Anti-Fibrotic Mechanisms of the Quercetin.

The American journal of Chinese medicine · 2025 · Liu X et al.
Review🟡
Key finding

Advances and Perspectives on the Anti-Fibrotic Mechanisms of the Quercetin.

PMID: 40621627DOI: 10.1142/S0192415X25500545
View on PubMed